Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Agent against Tropical Parasites

12.07.2012
There is an urgent need for better drugs to treat African sleeping sickness. Würzburg scientists have developed a very promising new agent, which is now to be further optimized.

African sleeping sickness is caused by the tropical parasite Trypanosoma brucei. This unicellular, worm-shaped organism is endemic in Sub-Saharan Africa. It can be transmitted to humans through the bite of the tsetse fly. Infected people first get headaches and aching limbs, after which confusion, spasms and other symptoms follow at a later stage. Finally, the patients go into some kind of vegetative state and die. About 30,000 new infections occur each year.


Chemical structure of the agent quinolone amide, which kills off the pathogens responsible for the African sleeping sickness. Picture: Georg Hiltensperger / Nicola Jones

There are still no vaccines available against the pathogen and the drugs on offer have in part extreme side effects. Therefore, better drugs are urgently needed for the treatment of this disease. This is what pharmacologists, medical researchers and biologists of the University of Würzburg are currently working on. Successfully too: The scientists present a new potent agent against trypanosoma in the "Journal of Medicinal Chemistry".

Quinolone amide disrupts the cell division of the parasites

The new agent is a molecule classified into the group of quinolone amides. It has been developed by Würzburg pharmacologists; in cell cultures, the agent reliably kills off the pathogens responsible for the sleeping sickness – even when administered in small doses.

How does the quinolone amide attack the parasites? Analyses conducted at the Biocenter have shown that the agent interacts with the so-called kinetoplasts. These structures are only found in trypanosomes. "Without the kinetoplasts, the cell division and consequently the reproduction of the pathogens halts," says Nicola Jones at the Biocenter.

Objective: To make the agent soluble in water

Next, it must be clarified in an animal model whether the new agent works effectively in an infected organism as well. However, there is still a hurdle to be cleared before doing this. Quinolone amide is poorly soluble in water. "Therefore, processing it into a drug is very difficult; furthermore, the agent is not absorbed into the blood effectively enough," explains Georg Hiltensperger at the Department of Pharmaceutical Chemistry.

So the bioavailability of the agent still needs to be improved. In order to achieve this, the researchers pursue two strategies. Firstly, they are testing whether the quinolone amide can be made better soluble in water without loss of effectiveness by means of chemical modifications. Secondly, they are trying to encapsulate the agent with pharmaceutical technologies so effectively that it is delivered to the blood in sufficient quantities after oral administration.

Groups involved in the research

The scientists at the University of Würzburg involved in this research include the study groups of professors Ulrike Holzgrabe and Lorenz Meinel (Pharmacy), Markus Engstler (Biology) and Holger Braunschweig (Chemistry). The tropical medicine expert August Stich of the Medical Mission Institute Würzburg and the Basel researcher Marcel Kaiser are also contributing to this research.
The results were achieved at the Collaborative Research Center (SFB) 630 (Recognition, Preparation and Functional Analysis of Agents against Infectious Diseases) of the University of Würzburg. The SFB is funded by the German Research Foundation.

"Synthesis and Structure-Activity Relationships of New Quinolone-Type Molecules against Trypanosoma brucei", Georg Hiltensperger, Nicola G. Jones, Sabine Niedermeier, August Stich, Marcel Kaiser, Jamin Jung, Sebastian Puhl, Alexander Damme, Holger Braunschweig, Lorenz Meinel, Markus Engstler, and Ulrike Holzgrabe. Journal of Medicinal Chemistry, 1 March 2012, 55 (6), pp 2538–2548, DOI: 10.1021/jm101439s

Contact persons

Prof. Dr. Ulrike Holzgrabe, Department of Pharmaceutical Chemistry at the University of Würzburg, T +49 (0)931 31-85461, holzgrab@pharmazie.uni-wuerzburg.de

Prof. Dr. Markus Engstler, Department of Zoology I (Cell and Developmental Biology), Biocenter at the University of Würzburg, T +49 (0)931 31-80060, markus.engstler@biozentrum.uni-wuerzburg.de

Robert Emmerich | idw
Further information:
http://www.uni-wuerzburg.de

More articles from Life Sciences:

nachricht The Secret of the Rock Drawings
24.05.2019 | Max-Planck-Institut für Chemie

nachricht Chemical juggling with three particles
24.05.2019 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New studies increase confidence in NASA's measure of Earth's temperature

A new assessment of NASA's record of global temperatures revealed that the agency's estimate of Earth's long-term temperature rise in recent decades is accurate to within less than a tenth of a degree Fahrenheit, providing confidence that past and future research is correctly capturing rising surface temperatures.

The most complete assessment ever of statistical uncertainty within the GISS Surface Temperature Analysis (GISTEMP) data product shows that the annual values...

Im Focus: The geometry of an electron determined for the first time

Physicists at the University of Basel are able to show for the first time how a single electron looks in an artificial atom. A newly developed method enables them to show the probability of an electron being present in a space. This allows improved control of electron spins, which could serve as the smallest information unit in a future quantum computer. The experiments were published in Physical Review Letters and the related theory in Physical Review B.

The spin of an electron is a promising candidate for use as the smallest information unit (qubit) of a quantum computer. Controlling and switching this spin or...

Im Focus: Self-repairing batteries

UTokyo engineers develop a way to create high-capacity long-life batteries

Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...

Im Focus: Quantum Cloud Computing with Self-Check

With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.

Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...

Im Focus: Accelerating quantum technologies with materials processing at the atomic scale

'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.

However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

On Mars, sands shift to a different drum

24.05.2019 | Physics and Astronomy

Piedmont Atlanta first in Georgia to offer new minimally invasive treatment for emphysema

24.05.2019 | Medical Engineering

Chemical juggling with three particles

24.05.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>